Skip to content
2000
Volume 2, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007

Abstract

L. belongs to the Scrophulariaceae family. The most significant is digitoxin, a very toxic substance that builds up in the body and is impenetrable in water. For millennia, people have utilized the medication Digitalis to treat cardiac problems induced by obesity. External triggers like strenuous exercise, emotional stress, eating, exposure to extreme weather, sexual activity, coffee and alcohol consumption, and use of cocaine or marijuana temporarily increase the risk of having a myocardial infarction. A person's genetic makeup influences disease progression, the presence of chronic risk factors, and lifestyle choices. Despite various educational programs, the fight against obesity does not appear to be successful. According to WHO (World Health Organisation) statistics, 13 percent of adults over the age of 18 are obese, and 39 percent are overweight. Being overweight or obese significantly raises the chance of developing disorders, including coronary heart disease. Digitalis is primarily used to treat heart conditions. It encourages and stimulates the action of all muscle tissues in cases of clogged heart failure. The herb improves heart nutrient absorption by forcing more blood into the coronaries. Digitalis aids in the repair and regulation of the heart's function when blood circulation is hampered.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X261528231116134608
2024-01-01
2024-11-26
Loading full text...

Full text loading...

/deliver/fulltext/cis/2/1/CIS-2-E2210299X261528.html?itemId=/content/journals/cis/10.2174/012210299X261528231116134608&mimeType=html&fmt=ahah

References

  1. RanaSonali SinghSuneeta BishtA. S. Digitalis Purpurea L: An overview on important medicinal plant. Advances in Agriculture For Doubling Farmers’ IncomeBFC Publications Private Limited2022190194
    [Google Scholar]
  2. RobertsM.M. PorterR. Literature & medicine during the eighteenth century.Taylor & Francis2022
    [Google Scholar]
  3. BricknellC. The royal horticultural society A-Z encyclopedia of garden plant.London, EnglandDorling Kindersley2003
    [Google Scholar]
  4. ZahidH. RizwaniG.H. Digitalis purpurea L.: A concise drug review with probable clinical uses.Hamdard Med.20165922532
    [Google Scholar]
  5. Kinne-SaffranE. KinneR.K.H. Herbal diuretics revisited: From “wise women” to William Withering.Am. J. Nephrol.2002222-311211810.1159/00006374812097727
    [Google Scholar]
  6. GrovesM.J. BissetN.G. A note on the use of topical Digitalis prior to William Withering.J. Ethnopharmacol.19913529910310.1016/0378‑8741(91)90061‑H1809828
    [Google Scholar]
  7. DavisR.C. HobbsF.D. LipG.Y. ABC of heart failure: History and epidemiology.BMJ20003207226394210.1136/bmj.320.7226.3910617530
    [Google Scholar]
  8. BuckalewV.M. Endogenous digitalis-like factors. An historical overview.Front. Biosci.2005101-32325233410.2741/170115970498
    [Google Scholar]
  9. HeinoR. Vara Lakande Vaxter: A natural path to a healthier life.Prisma publishing houseStockholm2001
    [Google Scholar]
  10. TylerV.E. BradyL.R. RobberJ.E. Pharmacognosy.9th edPhiladelphia, USALea and Febiger1988164170
    [Google Scholar]
  11. NegiSJ BishtVK BhandariAK SundriyalRC Determination of mineral contents of Digitalis purpurea L. and Digitalis lanata Ehrh.J. Soil Sci. Plant Nutr.20121246926
    [Google Scholar]
  12. WhalenK. FinkelR. PanavelilT.A. Lippincott illustrated reviews: Pharmacology, Wolters Kluwer6th ed.2015263265
    [Google Scholar]
  13. SmithTW The fundamental mechanism of inotropic action of Digitalis.Therapie.19894464315
    [Google Scholar]
  14. CsigeI. UjvárosyD. SzabóZ. LőrinczI. ParaghG. HarangiM. SomodiS. The impact of obesity on the cardiovascular system.J. Diabetes Res.2018201811210.1155/2018/340730630525052
    [Google Scholar]
  15. González-MuniesaP Mártinez-GonzálezMA HuFB Excessive fat deposition in obesity has a multifactorial aetiology, but is widely considered the result of disequilibrium between energy intake and expenditure.Despite specific public health
    [Google Scholar]
  16. AfshinA. ForouzanfarM.H. ReitsmaM.B. SurP. EstepK. LeeA. MarczakL. MokdadA.H. Moradi-LakehM. NaghaviM. SalamaJ.S. VosT. AbateK.H. AbbafatiC. AhmedM.B. Al-AlyZ. AlkerwiA. Al-RaddadiR. AmareA.T. AmberbirA. AmegahA.K. AminiE. AmrockS.M. AnjanaR.M. ÄrnlövJ. AsayeshH. BanerjeeA. BaracA. BayeE. BennettD.A. BeyeneA.S. BiadgilignS. BiryukovS. BjertnessE. BoneyaD.J. Campos-NonatoI. CarreroJ.J. CecilioP. CercyK. CiobanuL.G. CornabyL. DamtewS.A. DandonaL. DandonaR. DharmaratneS.D. DuncanB.B. EshratiB. EsteghamatiA. FeiginV.L. FernandesJ.C. FürstT. GebrehiwotT.T. GoldA. GonaP.N. GotoA. HabtewoldT.D. HadushK.T. Hafezi-NejadN. HayS.I. HorinoM. IslamiF. KamalR. KasaeianA. KatikireddiS.V. KengneA.P. KesavachandranC.N. KhaderY.S. KhangY.H. KhubchandaniJ. KimD. KimY.J. KinfuY. KosenS. KuT. DefoB.K. KumarG.A. LarsonH.J. LeinsaluM. LiangX. LimS.S. LiuP. LopezA.D. LozanoR. MajeedA. MalekzadehR. MaltaD.C. MazidiM. McAlindenC. McGarveyS.T. MengistuD.T. MensahG.A. MensinkG.B.M. MezgebeH.B. MirrakhimovE.M. MuellerU.O. NoubiapJ.J. ObermeyerC.M. OgboF.A. OwolabiM.O. PattonG.C. PourmalekF. QorbaniM. RafayA. RaiR.K. RanabhatC.L. ReinigN. SafiriS. SalomonJ.A. SanabriaJ.R. SantosI.S. SartoriusB. SawhneyM. SchmidhuberJ. SchutteA.E. SchmidtM.I. SepanlouS.G. ShamsizadehM. SheikhbahaeiS. ShinM.J. ShiriR. ShiueI. RobaH.S. SilvaD.A.S. SilverbergJ.I. SinghJ.A. StrangesS. SwaminathanS. Tabarés-SeisdedosR. TadeseF. TedlaB.A. TegegneB.S. TerkawiA.S. ThakurJ.S. TonelliM. Topor-MadryR. TyrovolasS. UkwajaK.N. UthmanO.A. VaezghasemiM. VasankariT. VlassovV.V. VollsetS.E. WeiderpassE. WerdeckerA. WesanaJ. WestermanR. YanoY. YonemotoN. YongaG. ZaidiZ. ZenebeZ.M. ZipkinB. MurrayC.J.L. Health effects of overweight and obesity in 195 countries over 25 years.N. Engl. J. Med.20173771132710.1056/NEJMoa161436228604169
    [Google Scholar]
  17. HalesCM CarrollMD FryarCD OgdenCL Prevalence of obesity among adults and youth: United States, 2015–2016.NCHS Data Brief.201728818
    [Google Scholar]
  18. JaacksL.M. VandevijvereS. PanA. McGowanC.J. WallaceC. ImamuraF. MozaffarianD. SwinburnB. EzzatiM. The obesity transition: Stages of the global epidemic.Lancet Diabetes Endocrinol.20197323124010.1016/S2213‑8587(19)30026‑930704950
    [Google Scholar]
  19. BlüherM. Obesity: global epidemiology and pathogenesis.Nat. Rev. Endocrinol.201915528829810.1038/s41574‑019‑0176‑830814686
    [Google Scholar]
  20. YanovskiJ.A. Trends in underweight and obesity-scale of the problem.Nat. Rev. Endocrinol.20181415610.1038/nrendo.2017.15729170540
    [Google Scholar]
  21. PuskaP. NishidaC. PorterD. World Health OrganizationObesity and overweight.World Health Organization200312
    [Google Scholar]
  22. HeymsfieldS.B. WaddenT.A. Mechanisms, pathophysiology, and management of obesity.N. Engl. J. Med.2017376325426610.1056/NEJMra151400928099824
    [Google Scholar]
  23. MurrayS. TullochA. GoldM.S. AvenaN.M. Hormonal and neural mechanisms of food reward, eating behaviour and obesity.Nat. Rev. Endocrinol.201410954055210.1038/nrendo.2014.9124958311
    [Google Scholar]
  24. FarooqiI.S. Defining the neural basis of appetite and obesity: From genes to behaviour.Clin. Med.201414328628910.7861/clinmedicine.14‑3‑28624889574
    [Google Scholar]
  25. AnandB.K. BrobeckJ.R. Hypothalamic control of food intake in rats and cats.Yale J. Biol. Med.195124212314014901884
    [Google Scholar]
  26. ZhangY. ProencaR. MaffeiM. BaroneM. LeopoldL. FriedmanJ.M. Positional cloning of the mouse obese gene and its human homologue.Nature1994372650542543210.1038/372425a07984236
    [Google Scholar]
  27. ColemanD.L. HummelK.P. Effects of parabiosis of normal with genetically diabetic mice.Am. J. Physiol.196921751298130410.1152/ajplegacy.1969.217.5.12985346292
    [Google Scholar]
  28. NabelE.G. Cardiovascular disease.N. Engl. J. Med.20033491607210.1056/NEJMra03509812840094
    [Google Scholar]
  29. CooperR. CutlerJ. Desvigne-NickensP. FortmannS.P. FriedmanL. HavlikR. HogelinG. MarlerJ. McGovernP. MoroscoG. MoscaL. PearsonT. StamlerJ. StryerD. ThomT. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the national conference on cardiovascular disease prevention.Circulation2000102253137314710.1161/01.CIR.102.25.313711120707
    [Google Scholar]
  30. ČulićV. Acute risk factors for myocardial infarction.Int. J. Cardiol.2007117226026910.1016/j.ijcard.2006.05.01116860887
    [Google Scholar]
  31. PoirierP. GilesT.D. BrayG.A. HongY. SternJ.S. Pi-SunyerF.X. EckelR.H. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss.Circulation2006113689891810.1161/CIRCULATIONAHA.106.17101616380542
    [Google Scholar]
  32. RathoreV. SinghN. MahatR.K. KocakM.Z. FidanK. AyazogluT.A. Aydin KarahanY.G. OnkD. AkarE. YolcuA. Risk factors for acute myocardial infarction: A review.Eurasian J. Med. Investig.20182117
    [Google Scholar]
  33. NigamP.K. Biochemical markers of myocardial injury.Indian J. Clin. Biochem.2007221101710.1007/BF0291287423105645
    [Google Scholar]
  34. NaikP. Biochemistry.3rdNew DelhiJaypee Brothers Medical publishers2010575591
    [Google Scholar]
  35. BhagwatK PadminiH Co-relation between lactate dehydrogenase and creatine kinase-MB in acute myocardial infarction.IJARPB20144
    [Google Scholar]
  36. HaassM. KitzmanD.W. AnandI.S. MillerA. ZileM.R. MassieB.M. CarsonP.E. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: Results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.Circ. Heart Fail.20114332433110.1161/CIRCHEARTFAILURE.110.95989021350053
    [Google Scholar]
  37. HegazyMA MansourKS AlzyatAM MohammadMA HegazyAA Myocardial infarction: Risk factors, pathophysiology, classification, assessment and management.Cardiol Res Rep.202245
    [Google Scholar]
  38. NeumannF.J. Sousa-UvaM. AhlssonA. AlfonsoF. BanningA.P. BenedettoU. ByrneR.A. ColletJ.P. FalkV. HeadS.J. JüniP. KastratiA. KollerA. KristensenS.D. NiebauerJ. RichterD.J. SeferovićP.M. SibbingD. StefaniniG.G. WindeckerS. YadavR. ZembalaM.O. WijnsW. GlineurD. AboyansV. AchenbachS. AgewallS. AndreottiF. BarbatoE. BaumbachA. BrophyJ. BuenoH. CalvertP.A. CapodannoD. DavierwalaP.M. DelgadoV. DudekD. FreemantleN. Funck-BrentanoC. GaemperliO. GielenS. GilardM. GorenekB. HaasenritterJ. HaudeM. IbanezB. IungB. JeppssonA. KatritsisD. KnuutiJ. KolhP. Leite-MoreiraA. LundL.H. MaisanoF. MehilliJ. MetzlerB. MontalescotG. PaganoD. PetronioA.S. PiepoliM.F. PopescuB.A. SádabaR. ShlyakhtoE. SilberS. SimpsonI.A. SparvD. TavillaG. ThieleH. TousekP. Van BelleE. VranckxP. WitkowskiA. ZamoranoJ.L. RoffiM. WindeckerS. AboyansV. AgewallS. BarbatoE. BuenoH. CocaA. ColletJ-P. ComanI.M. DeanV. DelgadoV. FitzsimonsD. GaemperliO. HindricksG. IungB. JüniP. KatusH.A. KnuutiJ. LancellottiP. LeclercqC. McDonaghT.A. PiepoliM.F. PonikowskiP. RichterD.J. RoffiM. ShlyakhtoE. Sousa-UvaM. SimpsonI.A. ZamoranoJ.L. PaganoD. FreemantleN. Sousa-UvaM. ChettibiM. SisakianH. MetzlerB. İbrahimovF. StelmashokV.I. PostadzhiyanA. SkoricB. EftychiouC. KalaP. TerkelsenC.J. MagdyA. EhaJ. NiemeläM. KedevS. MotreffP. AladashviliA. MehilliJ. KanakakisI-G. BeckerD. GudnasonT. PeaceA. RomeoF. BajraktariG. KerimkulovaA. RudzītisA. GhazzalZ. KibarskisA. PereiraB. XuerebR.G. HofmaS.H. SteigenT.K. WitkowskiA. de OliveiraE.I. MotS. DuplyakovD. ZavattaM. BeleslinB. KovarF. BuncM. OjedaS. WittN. JegerR. AddadF. AkdemirR. ParkhomenkoA. HendersonR. 2018 ESC/EACTS Guidelines on myocardial revascularization.Eur. Heart J.20194028716510.1093/eurheartj/ehy39430165437
    [Google Scholar]
  39. DaviesM.J. CORONARY DISEASE: The pathophysiology of acute coronary syndromes.Br. Heart J.200083336136610.1136/heart.83.3.36110677422
    [Google Scholar]
  40. FalkE. ShahP.K. FusterV. Coronary plaque disruption.Circulation199592365767110.1161/01.CIR.92.3.6577634481
    [Google Scholar]
  41. BentzonJ.F. OtsukaF. VirmaniR. FalkE. Mechanisms of plaque formation and rupture.Circ. Res.2014114121852186610.1161/CIRCRESAHA.114.30272124902970
    [Google Scholar]
  42. SzmitkoP.E. WangC.H. WeiselR.D. de AlmeidaJ.R. AndersonT.J. VermaS. New markers of inflammation and endothelial cell activation: Part I.Circulation2003108161917192310.1161/01.CIR.0000089190.95415.9F14568885
    [Google Scholar]
  43. AnkerS.D. Comin ColetJ. FilippatosG. WillenheimerR. DicksteinK. DrexlerH. LüscherT.F. BartB. BanasiakW. NiegowskaJ. KirwanB.A. MoriC. von Eisenhart RotheB. PocockS.J. Poole-WilsonP.A. PonikowskiP. Ferric carboxymaltose in patients with heart failure and iron deficiency.N. Engl. J. Med.2009361252436244810.1056/NEJMoa090835519920054
    [Google Scholar]
  44. ReddyB.A. Digitalis therapy in patients with congestive heart failure.Int. J. Pharm. Sci. Rev. Res.2010329095
    [Google Scholar]
  45. de GraafJ.C. BangaJ.D. MoncadaS. PalmerR.M. de GrootP.G. SixmaJ.J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.Circulation19928562284229010.1161/01.CIR.85.6.22841591842
    [Google Scholar]
  46. SalomonJ.A. VosT. HoganD.R. GagnonM. NaghaviM. MokdadA. BegumN. ShahR. KaryanaM. KosenS. FarjeM.R. MoncadaG. DuttaA. SazawalS. DyerA. SeilerJ. AboyansV. BakerL. BaxterA. BenjaminE.J. BhallaK. AbdulhakA.B. BlythF. BourneR. BraithwaiteT. BrooksP. BrughaT.S. Bryan-HancockC. BuchbinderR. BurneyP. CalabriaB. ChenH. ChughS.S. CooleyR. CriquiM.H. CrossM. DabhadkarK.C. DahodwalaN. DavisA. DegenhardtL. Díaz-TornéC. DorseyE.R. DriscollT. EdmondK. ElbazA. EzzatiM. FeiginV. FerriC.P. FlaxmanA.D. FloodL. FransenM. FuseK. GabbeB.J. GillumR.F. HaagsmaJ. HarrisonJ.E. HavmoellerR. HayR.J. Hel-BaquiA. HoekH.W. HoffmanH. HogelandE. HoyD. JarvisD. JonasJ.B. KarthikeyanG. KnowltonL.M. LathleanT. LeasherJ.L. LimS.S. LipshultzS.E. LopezA.D. LozanoR. LyonsR. MalekzadehR. MarcenesW. MarchL. MargolisD.J. McGillN. McGrathJ. MensahG.A. MeyerA-C. MichaudC. MoranA. MoriR. MurdochM.E. NaldiL. NewtonC.R. NormanR. OmerS.B. OsborneR. PearceN. Perez-RuizF. PericoN. PesudovsK. PhillipsD. PourmalekF. PrinceM. RehmJ.T. RemuzziG. RichardsonK. RoomR. SahaS. SampsonU. Sanchez-RieraL. Segui-GomezM. ShahrazS. ShibuyaK. SinghD. SliwaK. SmithE. SoerjomataramI. SteinerT. StolkW.A. StovnerL.J. SudfeldC. TaylorH.R. TleyjehI.M. van der WerfM.J. WatsonW.L. WeatherallD.J. WeintraubR. WeisskopfM.G. WhitefordH. WilkinsonJ.D. WoolfA.D. ZhengZ-J. MurrayC.J.L. Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010.Lancet201238098592129214310.1016/S0140‑6736(12)61680‑823245605
    [Google Scholar]
  47. WinnickaK. BielawskiK. BielawskaA. SurażyńskiA. Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells.Biol. Pharm. Bull.20083161131114010.1248/bpb.31.113118520043
    [Google Scholar]
  48. BagrovA.Y. FedorovaO.V. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension.Front. Biosci.2005101-32250225610.2741/169415970491
    [Google Scholar]
  49. VirgadamoS. CharnigoR. DarratY. MoralesG. ElayiC.S. Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction.World J. Cardiol.201571180881610.4330/wjc.v7.i11.80826635929
    [Google Scholar]
  50. MurrayC.J.L. VosT. LozanoR. NaghaviM. FlaxmanA.D. MichaudC. EzzatiM. ShibuyaK. SalomonJ.A. AbdallaS. AboyansV. AbrahamJ. AckermanI. AggarwalR. AhnS.Y. AliM.K. AlMazroaM.A. AlvaradoM. AndersonH.R. AndersonL.M. AndrewsK.G. AtkinsonC. BaddourL.M. BahalimA.N. Barker-ColloS. BarreroL.H. BartelsD.H. BasáñezM-G. BaxterA. BellM.L. BenjaminE.J. BennettD. BernabéE. BhallaK. BhandariB. BikbovB. AbdulhakA.B. BirbeckG. BlackJ.A. BlencoweH. BloreJ.D. BlythF. BolligerI. BonaventureA. BoufousS. BourneR. BoussinesqM. BraithwaiteT. BrayneC. BridgettL. BrookerS. BrooksP. BrughaT.S. Bryan-HancockC. BucelloC. BuchbinderR. BuckleG. BudkeC.M. BurchM. BurneyP. BursteinR. CalabriaB. CampbellB. CanterC.E. CarabinH. CarapetisJ. CarmonaL. CellaC. CharlsonF. ChenH. ChengA.T-A. ChouD. ChughS.S. CoffengL.E. ColanS.D. ColquhounS. ColsonK.E. CondonJ. ConnorM.D. CooperL.T. CorriereM. CortinovisM. de VaccaroK.C. CouserW. CowieB.C. CriquiM.H. CrossM. DabhadkarK.C. DahiyaM. DahodwalaN. Damsere-DerryJ. DanaeiG. DavisA. LeoD.D. DegenhardtL. DellavalleR. DelossantosA. DenenbergJ. DerrettS. Des JarlaisD.C. DharmaratneS.D. DheraniM. Diaz-TorneC. DolkH. DorseyE.R. DriscollT. DuberH. EbelB. EdmondK. ElbazA. AliS.E. ErskineH. ErwinP.J. EspindolaP. EwoigbokhanS.E. FarzadfarF. FeiginV. FelsonD.T. FerrariA. FerriC.P. FèvreE.M. FinucaneM.M. FlaxmanS. FloodL. ForemanK. ForouzanfarM.H. FowkesF.G.R. FransenM. FreemanM.K. GabbeB.J. GabrielS.E. GakidouE. GanatraH.A. GarciaB. GaspariF. GillumR.F. GmelG. Gonzalez-MedinaD. GosselinR. GraingerR. GrantB. GroegerJ. GuilleminF. GunnellD. GuptaR. HaagsmaJ. HaganH. HalasaY.A. HallW. HaringD. HaroJ.M. HarrisonJ.E. HavmoellerR. HayR.J. HigashiH. HillC. HoenB. HoffmanH. HotezP.J. HoyD. HuangJ.J. IbeanusiS.E. JacobsenK.H. JamesS.L. JarvisD. JasrasariaR. JayaramanS. JohnsN. JonasJ.B. KarthikeyanG. KassebaumN. KawakamiN. KerenA. KhooJ-P. KingC.H. KnowltonL.M. KobusingyeO. KorantengA. KrishnamurthiR. LadenF. LallooR. LaslettL.L. LathleanT. LeasherJ.L. LeeY.Y. LeighJ. LevinsonD. LimS.S. LimbE. LinJ.K. LipnickM. LipshultzS.E. LiuW. LoaneM. OhnoS.L. LyonsR. MabweijanoJ. MacIntyreM.F. MalekzadehR. MallingerL. ManivannanS. MarcenesW. MarchL. MargolisD.J. MarksG.B. MarksR. MatsumoriA. MatzopoulosR. MayosiB.M. McAnultyJ.H. McDermottM.M. McGillN. McGrathJ. Medina-MoraM.E. MeltzerM. MemishZ.A. MensahG.A. MerrimanT.R. MeyerA-C. MiglioliV. MillerM. MillerT.R. MitchellP.B. MockC. MocumbiA.O. MoffittT.E. MokdadA.A. MonastaL. MonticoM. Moradi-LakehM. MoranA. MorawskaL. MoriR. MurdochM.E. MwanikiM.K. NaidooK. NairM.N. NaldiL. NarayanK.M.V. NelsonP.K. NelsonR.G. NevittM.C. NewtonC.R. NolteS. NormanP. NormanR. O’DonnellM. O’HanlonS. OlivesC. OmerS.B. OrtbladK. OsborneR. OzgedizD. PageA. PahariB. PandianJ.D. RiveroA.P. PattenS.B. PearceN. PadillaR.P. Perez-RuizF. PericoN. PesudovsK. PhillipsD. PhillipsM.R. PierceK. PionS. PolanczykG.V. PolinderS. PopeC.A.III PopovaS. PorriniE. PourmalekF. PrinceM. PullanR.L. RamaiahK.D. RanganathanD. RazaviH. ReganM. RehmJ.T. ReinD.B. RemuzziG. RichardsonK. RivaraF.P. RobertsT. RobinsonC. De LeònF.R. RonfaniL. RoomR. RosenfeldL.C. RushtonL. SaccoR.L. SahaS. SampsonU. Sanchez-RieraL. SanmanE. SchwebelD.C. ScottJ.G. Segui-GomezM. ShahrazS. ShepardD.S. ShinH. ShivakotiR. SilberbergD. SinghD. SinghG.M. SinghJ.A. SingletonJ. SleetD.A. SliwaK. SmithE. SmithJ.L. StapelbergN.J.C. SteerA. SteinerT. StolkW.A. StovnerL.J. SudfeldC. SyedS. TamburliniG. TavakkoliM. TaylorH.R. TaylorJ.A. TaylorW.J. ThomasB. ThomsonW.M. ThurstonG.D. TleyjehI.M. TonelliM. TowbinJ.A. TruelsenT. TsilimbarisM.K. UbedaC. UndurragaE.A. van der WerfM.J. van OsJ. VavilalaM.S. VenketasubramanianN. WangM. WangW. WattK. WeatherallD.J. WeinstockM.A. WeintraubR. WeisskopfM.G. WeissmanM.M. WhiteR.A. WhitefordH. WiebeN. WiersmaS.T. WilkinsonJ.D. WilliamsH.C. WilliamsS.R.M. WittE. WolfeF. WoolfA.D. WulfS. YehP-H. ZaidiA.K.M. ZhengZ-J. ZoniesD. LopezA.D. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet201238098592197222310.1016/S0140‑6736(12)61689‑423245608
    [Google Scholar]
  51. BorronS.W. BismuthC. MuszynskiJ. Advances in the management of digoxin toxicity in the older patient.Drugs Aging1997101183310.2165/00002512‑199710010‑000039111705
    [Google Scholar]
  52. HauptmanP.J. KellyR.A. Digitalis.Circulation19999991265127010.1161/01.CIR.99.9.126510069797
    [Google Scholar]
  53. GeeringK. Na,K-ATPase.Curr. Opin. Nephrol. Hypertens.19976543443910.1097/00041552‑199709000‑000059327201
    [Google Scholar]
  54. BlausteinM.P. RobinsonS.W. GottliebS.S. BalkeC.W. HamlynJ.M. Sex, digitalis, and the sodium pump.Mol. Interv.2003326872, 5010.1124/mi.3.2.6814993426
    [Google Scholar]
  55. GosselinkA.T.M. van VeldhuisenD.J. CrijnsH.J.G.M. When, and when not, to use digoxin in the elderly.Drugs Aging199710641142010.2165/00002512‑199710060‑000029205847
    [Google Scholar]
  56. EwyG.A. GrovesB.M. BallM.F. NimmoL. JacksonB. MarcusF. Digoxin metabolism in obesity.Circulation197144581081410.1161/01.CIR.44.5.8105115072
    [Google Scholar]
  57. VöhringerH.F. RietbrockN. Digitalis therapy in renal failure with special regard to digitoxin.Int. J. Clin. Pharmacol. Ther. Toxicol.19811941751847021432
    [Google Scholar]
/content/journals/cis/10.2174/012210299X261528231116134608
Loading
/content/journals/cis/10.2174/012210299X261528231116134608
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test